Use of intravenous sulprostone for the termination of pregnancy with fetal death in second and early third trimester of pregnancy

Anita K. Mohan, Mariam Mathew, Syed G. Rizvi

Research output: Contribution to journalArticle

1 Citation (Scopus)

Abstract

Objective: To study the efficacy of intravenous sulprostone (Nalador) for the termination of pregnancy with fetal death in second and early third trimester of pregnancy. Methods: This is a retrospective collection and analysis of data from a cohort of 97 women with fetal death between 12-30 weeks gestation treated with intravenous infusion of a prostaglandin analogue, sulprostone, to achieve expulsion of the products of conception. It was conducted in the Department of Obstetrics and Gynaecology, Sultan Qaboos University Hospital, Oman. The data collected was from January 2000 to December 2005. Sulprostone was started as an intravenous infusion of 15μgm/hr and titrated to a maximum of 240μgm/hr to a total dose of 1500μgm/day, as per the departmental protocol. The patients’ demographic data, gestational age, induction-expulsion interval, the need for evacuation, side effects and complications were studied. Results: Out of the 97 women who received sulprostone, 90 aborted within 24 hours. The average induction-expulsion interval was 11.9 ± 8.0 hours. Sulprostone use was associated with few side effects and was well tolerated by patients. Although most of the patients required evacuation and curettage, the blood loss was minimal. Only six out of 97 women required blood transfusions and two patients needed hysterotomy. Conclusion: We found sulprostone an efficient drug for termination of pregnancy with fetal death in second and early third trimester of pregnancy.

Original languageEnglish
Pages (from-to)306-309
Number of pages4
JournalSultan Qaboos University Medical Journal
Volume8
Issue number3
Publication statusPublished - Nov 1 2008

Fingerprint

Fetal Death
Third Pregnancy Trimester
Pregnancy
Intravenous Infusions
Hysterotomy
Oman
Synthetic Prostaglandins
Hospital Obstetrics and Gynecology Department
Curettage
sulprostone
Gynecology
Blood Transfusion
Gestational Age
Demography
Pharmaceutical Preparations

Keywords

  • Intrauterine fetal death
  • Prostaglandin
  • Sulprostone

ASJC Scopus subject areas

  • Medicine(all)

Cite this

@article{807ed14132f84a2bb7fb13de84bd1772,
title = "Use of intravenous sulprostone for the termination of pregnancy with fetal death in second and early third trimester of pregnancy",
abstract = "Objective: To study the efficacy of intravenous sulprostone (Nalador) for the termination of pregnancy with fetal death in second and early third trimester of pregnancy. Methods: This is a retrospective collection and analysis of data from a cohort of 97 women with fetal death between 12-30 weeks gestation treated with intravenous infusion of a prostaglandin analogue, sulprostone, to achieve expulsion of the products of conception. It was conducted in the Department of Obstetrics and Gynaecology, Sultan Qaboos University Hospital, Oman. The data collected was from January 2000 to December 2005. Sulprostone was started as an intravenous infusion of 15μgm/hr and titrated to a maximum of 240μgm/hr to a total dose of 1500μgm/day, as per the departmental protocol. The patients’ demographic data, gestational age, induction-expulsion interval, the need for evacuation, side effects and complications were studied. Results: Out of the 97 women who received sulprostone, 90 aborted within 24 hours. The average induction-expulsion interval was 11.9 ± 8.0 hours. Sulprostone use was associated with few side effects and was well tolerated by patients. Although most of the patients required evacuation and curettage, the blood loss was minimal. Only six out of 97 women required blood transfusions and two patients needed hysterotomy. Conclusion: We found sulprostone an efficient drug for termination of pregnancy with fetal death in second and early third trimester of pregnancy.",
keywords = "Intrauterine fetal death, Prostaglandin, Sulprostone",
author = "Mohan, {Anita K.} and Mariam Mathew and Rizvi, {Syed G.}",
year = "2008",
month = "11",
day = "1",
language = "English",
volume = "8",
pages = "306--309",
journal = "Sultan Qaboos University Medical Journal",
issn = "2075-051X",
publisher = "Sultan Qaboos University",
number = "3",

}

TY - JOUR

T1 - Use of intravenous sulprostone for the termination of pregnancy with fetal death in second and early third trimester of pregnancy

AU - Mohan, Anita K.

AU - Mathew, Mariam

AU - Rizvi, Syed G.

PY - 2008/11/1

Y1 - 2008/11/1

N2 - Objective: To study the efficacy of intravenous sulprostone (Nalador) for the termination of pregnancy with fetal death in second and early third trimester of pregnancy. Methods: This is a retrospective collection and analysis of data from a cohort of 97 women with fetal death between 12-30 weeks gestation treated with intravenous infusion of a prostaglandin analogue, sulprostone, to achieve expulsion of the products of conception. It was conducted in the Department of Obstetrics and Gynaecology, Sultan Qaboos University Hospital, Oman. The data collected was from January 2000 to December 2005. Sulprostone was started as an intravenous infusion of 15μgm/hr and titrated to a maximum of 240μgm/hr to a total dose of 1500μgm/day, as per the departmental protocol. The patients’ demographic data, gestational age, induction-expulsion interval, the need for evacuation, side effects and complications were studied. Results: Out of the 97 women who received sulprostone, 90 aborted within 24 hours. The average induction-expulsion interval was 11.9 ± 8.0 hours. Sulprostone use was associated with few side effects and was well tolerated by patients. Although most of the patients required evacuation and curettage, the blood loss was minimal. Only six out of 97 women required blood transfusions and two patients needed hysterotomy. Conclusion: We found sulprostone an efficient drug for termination of pregnancy with fetal death in second and early third trimester of pregnancy.

AB - Objective: To study the efficacy of intravenous sulprostone (Nalador) for the termination of pregnancy with fetal death in second and early third trimester of pregnancy. Methods: This is a retrospective collection and analysis of data from a cohort of 97 women with fetal death between 12-30 weeks gestation treated with intravenous infusion of a prostaglandin analogue, sulprostone, to achieve expulsion of the products of conception. It was conducted in the Department of Obstetrics and Gynaecology, Sultan Qaboos University Hospital, Oman. The data collected was from January 2000 to December 2005. Sulprostone was started as an intravenous infusion of 15μgm/hr and titrated to a maximum of 240μgm/hr to a total dose of 1500μgm/day, as per the departmental protocol. The patients’ demographic data, gestational age, induction-expulsion interval, the need for evacuation, side effects and complications were studied. Results: Out of the 97 women who received sulprostone, 90 aborted within 24 hours. The average induction-expulsion interval was 11.9 ± 8.0 hours. Sulprostone use was associated with few side effects and was well tolerated by patients. Although most of the patients required evacuation and curettage, the blood loss was minimal. Only six out of 97 women required blood transfusions and two patients needed hysterotomy. Conclusion: We found sulprostone an efficient drug for termination of pregnancy with fetal death in second and early third trimester of pregnancy.

KW - Intrauterine fetal death

KW - Prostaglandin

KW - Sulprostone

UR - http://www.scopus.com/inward/record.url?scp=85040086589&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85040086589&partnerID=8YFLogxK

M3 - Article

VL - 8

SP - 306

EP - 309

JO - Sultan Qaboos University Medical Journal

JF - Sultan Qaboos University Medical Journal

SN - 2075-051X

IS - 3

ER -